ADCY5 Antikörper

Produktnummer ABIN7634138

Produktdetails anti-ADCY5 Antikörper

Target: ADCY5 (Adenylate Cyclase 5 (ADCY5))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ADCY5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: Polyclonal Antibody to Adenylate Cyclase 5 (ADCY5)

Spezifität: The antibody is a rabbit polyclonal antibody raised against ADCY5. It has been selected for its ability to recognize ADCY5 in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: RPB415Hu01Recombinant Adenylate Cyclase 5 (ADCY5)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.01-2 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu ADCY5

Target: ADCY5 (Adenylate Cyclase 5 (ADCY5))

Andere Bezeichnung: ADCY5 (ADCY5 Produkte)

Hintergrund: Adenylate cyclase type V, ATP pyrophosphate-lyase 5

UniProt: O95622

Pathways: EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma